SCHEMBL30241511

SCHEMBL30241511

C=CC(=O)Nc1ccc2c(ccn2Cc2ccc(OC(F)(F)F)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNQ3 O43525 2/20 0.52
▸ KCNQ2 O43526 2/20 0.52
▸ KCNQ4 P56696 2/20 0.52
▸ KCNQ5 Q9NR82 2/20 0.52
▸ GCGR P47871 1/20 0.51
▸ EGFR P00533 1/20 0.49
▸ TEAD1 P28347 1/20 0.48
▸ MAOB P27338 1/20 0.46
▸ ERBB2 P04626 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ EPHX2 P34913 5/20 0.46
▸ HDAC8 Q9BY41 3/20 0.45
▸ HDAC6 Q9UBN7 3/20 0.45
▸ HDAC11 Q96DB2 1/20 0.45
▸ FGFR1 P11362 1/20 0.45
▸ FGFR4 P22455 1/20 0.45
▸ PPARA Q07869 1/20 0.44
▸ CACNA1H O95180 1/20 0.44
▸ TEK Q02763 2/20 0.43
▸ EPHB4 P54760 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23902673 1.00 KCNQ3 (0.52) KCNQ3KCNQ2KCNQ4KCNQ5GCGR
SCHEMBL23902658 0.89 EGFR (0.55) KCNQ3KCNQ2KCNQ4KCNQ5GCGR
SCHEMBL30241341 0.89 EGFR (0.55) KCNQ3KCNQ2KCNQ4KCNQ5GCGR
SCHEMBL30241388 0.84 KCNQ3 (0.66) KCNQ3KCNQ2KCNQ4KCNQ5EGFR
SCHEMBL23902686 0.84 KCNQ3 (0.66) KCNQ3KCNQ2KCNQ4KCNQ5EGFR
SCHEMBL23902645 0.82 ERBB2 (0.60) KCNQ3KCNQ2KCNQ4KCNQ5EGFR
SCHEMBL30241481 0.82 ERBB2 (0.60) KCNQ3KCNQ2KCNQ4KCNQ5EGFR
SCHEMBL23902638 0.82 EGFR (0.51) KCNQ3KCNQ2KCNQ4KCNQ5EGFR
SCHEMBL30364613 0.82 EGFR (0.51) KCNQ3KCNQ2KCNQ4KCNQ5EGFR
SCHEMBL23902662 0.82 KCNQ3 (0.53) KCNQ3KCNQ2KCNQ4KCNQ5EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4132907-A1 (1 H-INDOL-5-YL)ACRYLAMIDE DERIVATIVES AS INHIBITORS OF TEAD PROTEINS AND THE HIPPO-YAP1/TAZ SIGNALING CASCADE FOR THE TREATMENT OF CANCER SANOFI (FR) 2023-02-15 — — EP claimed
CN-115667216-A (1H-indol-5-yl) acrylamide derivatives as TEAD proteins and inhibitors of the HIPPO-YAP1/TAZ signaling cascade for the treatment of cancer 赛诺菲 2023-01-31 — — CN claimed
CN-115667216-B (1H-indol-5-yl) acrylamide derivatives as inhibitors of TEAD proteins and HIPPO-YAP1/TAZ signaling cascades for the treatment of cancer 赛诺菲 2025-02-18 — — CN disclosed
EP-4132907-A1 (1 H-INDOL-5-YL)ACRYLAMIDE DERIVATIVES AS INHIBITORS OF TEAD PROTEINS AND THE HIPPO-YAP1/TAZ SIGNALING CASCADE FOR THE TREATMENT OF CANCER SANOFI (FR) 2023-02-15 — — EP disclosed
CN-115667216-A (1H-indol-5-yl) acrylamide derivatives as TEAD proteins and inhibitors of the HIPPO-YAP1/TAZ signaling cascade for the treatment of cancer 赛诺菲 2023-01-31 — — CN disclosed
Send feedback